On June 4, 2019 Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, reported that President & CEO Gerald Commissiong will make a corporate presentation at the 9th Annual LD Micro Invitational Conference (Press release, Amarantus Biosciences, JUN 4, 2019, View Source [SID1234536859]). The presentation will be at 8:20am Pacific time on Wednesday, June 5th, 2019 in Track 5 at the Luxe Sunset Bel Air Hotel in Los Angeles.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!